# Application of Oral Bacteriotherapy to Promote Anal HPV Clearance in HIV Positive Individuals

> **NCT04099433** · NA · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 40 (estimated)

## Conditions studied

- HIV
- Anal Dysplasia

## Interventions

- **DIETARY_SUPPLEMENT:** Vivomixx
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04099433
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04099433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04099433, "Application of Oral Bacteriotherapy to Promote Anal HPV Clearance in HIV Positive Individuals". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04099433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*